Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Rang în acțiuni
#4336
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Preț acțiune
$3.87
Capitalizare de piață
$3.57B
Schimbare (1 zi)
-1.64%
Schimbare (1 an)
9.08%
Țară
CN
Tranzacționează Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Categorie
Healthcare
Raport P/B pentru Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Raport P/B la data de October 2026 TTM: 1.74
Conform celor mai recente rapoarte financiare și prețului acțiunilor Hubei Jumpcan Pharmaceutical Co., Ltd., raportul P/B actual (TTM) este 1.74. La sfârșitul anului 2024, compania avea un P/B de 1.81.
Istoricul raportului P/B pentru Hubei Jumpcan Pharmaceutical Co., Ltd. din 2001 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 1.74 | 4.72% |
| 2025 | 1.66 | -8.58% |
| 2024 | 1.81 | -20.64% |
| 2023 | 2.29 | 7.03% |
| 2022 | 2.14 | -22.64% |
| 2021 | 2.76 | 26.93% |
| 2020 | 2.18 | -32.61% |
| 2019 | 3.23 | -28.06% |
| 2018 | 4.49 | -36.34% |
| 2017 | 7.05 | 3.38% |
| 2016 | 6.82 | -15.47% |
| 2015 | 8.07 | 21.15% |
| 2014 | 6.66 | -37.14% |
| 2013 | 10.59 | 28.54% |
| 2012 | 8.24 | 390.60% |
| 2011 | 1.68 | -34.12% |
| 2010 | 2.55 | 54.33% |
| 2009 | 1.65 | 76.47% |
| 2008 | 0.94 | -55.17% |
| 2007 | 2.09 | 104.82% |
| 2006 | 1.02 | 4.08% |
| 2005 | 0.98 | -17.76% |
| 2004 | 1.19 | -24.51% |
| 2003 | 1.58 | -39.47% |
| 2002 | 2.61 | -31.82% |
| 2001 | 3.82 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 1.9834 | 14.09% |
DE
|
|
| 2.1139 | 21.60% |
DE
|
|
| 1.3124 | -24.51% |
JP
|
|
| 6.3468 | 265.09% |
CH
|
|
| 5.0287 | 189.27% |
IN
|
